Log in


Advancing translational life sciences research and academic technology transfer

  • Home
  • Zinc may prevent Barrett’s esophagus-related esophageal cancer, human study shows, Lankenau Medical Center

Zinc may prevent Barrett’s esophagus-related esophageal cancer, human study shows, Lankenau Medical Center

8 Jun 2020 11:15 AM | Anonymous

The micronutrient zinc administered orally as zinc gluconate (an over-the-counter lozenge) may help to prevent cancer of the esophagus in patients diagnosed with the pre-malignant condition called Barrett’s esophagus (BE), according to the results of a first-ever pilot study in humans conducted, in part, by investigators at the Lankenau Institute for Medical Research (LIMR) and physicians at the Lankenau Medical Center.

<<FULL STORY>>

Contact Us

admin@biostrategypartners.org
717-514-0436

P.O. Box 83 Boiling Springs, PA 17007



Copyright 2017, BioStrategy Partners. All rights reserved.   
Powered by Wild Apricot Membership Software